Home・Aandelen Lijst・Accuray Inc

Accuray Inc

Gesloten

SectorGezondheidszorg

0.27 -12.9

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.28

Max

0.31

Belangrijke statistieken
By Trading Economics
Inkomsten	2M -12M
Verkoop	2.6M 105M
EPS	-0.07
Winstmarge	-11.259
Werknemers	990
EBITDA	2.5M -813K

Aanbevelingen
By TipRanks
Aanbevelingen	Neutraal
12 Maanden Prognose	+12.9% upside

Dividenden
By Acuity
Volgende Winsten	12 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-22M 32M
Vorige openingsprijs	13.17
Vorige sluitingsprijs	0.27

Nieuwssentiment

By Acuity

50%

175 / 340 Rangschikking in Healthcare

Accuray Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 aug 2026, 20:02 UTC

Accuray Inc shares are higher today amid positive market sentiment and declining crude oil prices. Comments on potential peace talks with Iran also support the move.

3 aug 2026, 19:31 UTC

Accuray Inc shares are lower today, with no specific news identified to explain the decline, despite broader market gains.

31 jul 2026, 23:16 UTC

Accuray Inc shares are lower in after-market trading, with no specific news identified. Broader market pressures also impacted other tech companies, including Apple Inc.

30 jul 2026, 23:51 UTC

Accuray Inc shares are lower in after-market hours, with no specific news identified for the decline. Broader market conditions remain mixed amid geopolitical concerns.

29 jul 2026, 23:02 UTC

News

Accuray Inc. announced a $40 million debt exchange and $15 million equity investment to enhance its financial position, with shares trading higher after market close.

28 jul 2026, 23:16 UTC

Accuray Inc shares are trading lower in after-market hours, reflecting broader market pressures in the technology sector amid concerns over AI spending and competition.

27 jul 2026, 19:32 UTC

Accuray Inc's shares are declining today, hitting a low after an early high. Broader market conditions, including falling oil prices, may be influencing sentiment.

24 jul 2026, 19:11 UTC

Accuray Inc's shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains near its one-month low.

22 jul 2026, 18:51 UTC

Accuray Inc. shares are trading flat, remaining 7.82% below their 20-day moving average amid a lack of upward momentum.

20 jul 2026, 19:31 UTC

Accuray Inc shares are lower today, diverging from a recent trend of higher closes. Broader market dynamics may be impacting investor sentiment.

Peer Vergelijking

Prijswijziging

Accuray Inc Prognose

Koersdoel

By TipRanks

12.9% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 0.35 USD 12.9%

Hoogste 0.35 USD

Laagste 0.35 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Accuray Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Accuray Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

175 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.